Abstract
The objective is to determine the global population prevalence of rheumatoid arthritis (RA) based on population-based studies and assess factors that influence RA prevalence estimates. Four electronic databases were searched (ProQuest Central, MEDLINE, Web of Science, and EMBASE) for peer-reviewed English publications that report prevalence estimates of RA from 1980 and 2019. We included case–control studies, cross-sectional studies, and prospective or retrospective cohort studies in our search strategy. A random-effect meta-analysis model was used to produce the pooled prevalence estimates. The potential between-study heterogeneity was identified using sensitivity analysis, sub-group and meta-regression analyses. A total of 67 studies were included in the meta-analysis, containing 742,246 RA patients and 211,592,925 healthy controls in the study period. The global RA prevalence estimate was 0.46% (95% confidence interval [CI] 0.39–0.54; I2 = 99.9%) with a 95% prediction interval (0.06–1.27). The RA point-prevalence was 0.45% (95% CI 0.38–0.53%) between 1986 and 2014, while the pooled period-prevalence was 0.46% (95% CI 0.36% and 0.57%) from 1955 to 2015. The highest RA pooled prevalence (0.69%; 95% CI 0.47–0.95) was derived from linked data source studies. Based on meta-regression, the factors that explain the studies' heterogeneity of RA prevalence, including geographical location, the risk bias assessment of studies and sample size. The global prevalence of RA between 1980 and 2019 was 460 per 100,000 population, with variations due to geographical location and study methodology. Linked data are the preferred method to estimate RA population prevalence as they provide the best case ascertainment.
Similar content being viewed by others
Availability of data and material
Data are available within the article or its supplementary materials.
References
Shapira Y, Agmon-Levin N, Shoenfeld Y (2010) Geoepidemiology of autoimmune rheumatic diseases. Nat Rev Rheumatol 6:468–476. https://doi.org/10.1038/nrrheum.2010.86
Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J, Ronnelid J, Harris HE, Ulfgren AK, Rantapaa-Dahlqvist S, Eklund A, Padyukov L, Alfredsson L (2006) A new model for an aetiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 54:38–46. https://doi.org/10.1002/art.21575
Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J (2018) Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res 6:15. https://doi.org/10.1038/s41413-018-0016-9
Alam J, Jantan I, Bukhari SNA (2017) Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy. Biomed Pharmacother 92:615–633. https://doi.org/10.1016/j.biopha.2017.05.055
Pabón-Porras MA, Molina-Ríos S, Flórez-Suárez JB, Coral-Alvarado PX, Méndez-Patarroyo P, Quintana-López G (2019) Rheumatoid arthritis and systemic lupus erythematosus: pathophysiological mechanisms related to innate immune system. SAGE Open Med 7:2050312119876146. https://doi.org/10.1177/2050312119876146
Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, Kavanaugh A, McInnes IB, Solomon DH, Strand V, Yamamoto K (2018) Rheumatoid arthritis. Nat Rev Dis Primers 4:1–23. https://doi.org/10.1038/nrdp.2018.1
Liao KP, Alfredsson L, Karlson EW (2009) Environmental influences on risk for rheumatoid arthritis. Curr Opin Rheumatol 21:279–283. https://doi.org/10.1097/BOR.0b013e32832a2e16
Tobon GJ, Youinou P, Saraux A (2010) The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. J Autoimmun 35:10–14. https://doi.org/10.1016/j.jaut.2009.12.009
Australian Institute of Health and Welfare. Rheumatoid Arthritis. Australian Institution of Health and Welfare. https://www.aihw.gov.au/reports/arthritis-other-musculoskeletal-conditions/rheumatoid-arthritis/contents/who-gets-rheumatoid-arthritis. Accessed 30 Aug 2019.
Del Puente A, Knowler WC, Pettitt DJ, Bennett PH (1989) High incidence and prevalence of rheumatoid arthritis in Pima Indians. Am J Epidemiol 129:1170–1178
Harvey J, Lotze M, Stevens MB, Jacobson D (1981) Rheumatoid arthritis in a Chippewa band. Arthritis Rheum 24:717–721
Brighton S, Badenhorst J, Myers O (1988) The prevalence of rheumatoid arthritis in a rural African population. J Rheumatol 15:405–408
Silman AJ, Ollier W, Holligan S, Birrell F, Adebajo A, Asuzu MC, Thomson W, Pepper L (1993) Absence of rheumatoid arthritis in a rural Nigerian population. J Rheumatol 20:618–622
Carmona L, Cross M, Williams B, Lassere M, March L (2010) Rheumatoid arthritis. Best Pract Res Clin Rheumatol 24:733–745. https://doi.org/10.1016/j.berh.2010.10.001
Brownson RC, Petitti DB (2006) Applied epidemiology: theory to practice, 2nd edn. Oxford University Press, United Kingdom
Kvien TK (2004) Epidemiology and burden of illness of rheumatoid arthritis. PharmacoEconomics 22:1–12
Uhlig T, Moe RH, Kvien TK (2014) The burden of disease in rheumatoid arthritis. PharmacoEconomics 32:841–851. https://doi.org/10.1007/s40273-014-0174-6
Widdifield J (2019) Preventing rheumatoid arthritis: a global challenge. Clin Ther 41:1355–1365. https://doi.org/10.1016/j.clinthera.2019.04.019
Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C (2015) Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc 13:147–153
Gomersall JS, Jadotte YT, Xue Y, Lockwood S, Riddle D, Preda A (2015) Conducting systematic reviews of economic evaluations. Int J Evid Based Healthc 13:170–178
Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, Williams B, Gabriel S, Lassere M, Johns N, Buchbinder R, Woolf A, March L (2014) The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73:1316–1322. https://doi.org/10.1136/annrheumdis-2013-204627
MacGregor AJ (1995) Classification criteria for rheumatoid arthritis. Baillieres Clin Rheumatol 9:287–304
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Menard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581. https://doi.org/10.1002/art.27584
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6:e1000100. https://doi.org/10.1371/journal.pmed.1000100
The Joanna Briggs Institute. Global Prevalence of Rheumatoid Arthritis (Ra): A Systematic Review and Meta-Analysis. https://joannabriggs.org/node/1933. Accessed 14 Oct 2019
World Health Organisation. Global Health Observatory Data Repository. World Health Organisation. https://apps.who.int/gho/data/node.country.country-CUB?lang=en. Accessed 14 Oct 2019.
UNdata. The United Nations Data Repository. United Nations. https://data.un.org/Data.aspx?d=POP&f=tableCode:26. Accessed 14 Oct 2019
Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, Baker P, Smith E, Buchbinder R (2012) Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol 65:934–939. https://doi.org/10.1016/j.jclinepi.2011.11.014
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Controll Clin Trials 7:177–188
Rudan I, Sidhu S, Papana A, Meng SJ, Xin-Wei Y, Wang W, Campbell-Page RM, Demaio AR, Nair H, Sridhar D, Theodoratou E, Dowman B, Adeloye D, Majeed A, Car J, Campbell H, Wang W, Chan KY, Reference GHE (2015) Prevalence of rheumatoid arthritis in low- and middle-income countries: a systematic review and analysis. J Glob Health 5:010409. https://doi.org/10.7189/jogh.05.010409
Usenbo A, Kramer V, Young T, Musekiwa A (2015) Prevalence of arthritis in Africa: a systematic review and meta-analysis. PLoS ONE 10:e0133858. https://doi.org/10.1371/journal.pone.0133858
Schwarzer G. Package ‘meta’. The R foundation for Statistical Computing. [Cited 2019 Dec 19]. Available from: https://cran.r-project.org/web/packages/meta/meta.pdf
Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T (2013) Meta-analysis of prevalence. J Epidemiol Community Health 67:974–978. https://doi.org/10.1136/jech-2013-203104
Nyaga VN, Arbyn M, Aerts M (2014) Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Pub Health 72:39
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560
Davis G, Pecar B (2012) Quantitative methods for decision making using Excel, 1st edn. Oxford University Press, United Kingdom
Aert RC, Wicherts JM, Assen MA (2019) Publication bias examined in meta-analyses from psychology and medicine: a meta-meta-analysis. PLoS ONE 14:e0215052. https://doi.org/10.1371/journal.pone.0215052
The Joanna Briggs Institute. JBI Reviewer's Manual. https://wiki.joannabriggs.org/display/MANUAL/JBI+Reviewer%27s+Manual. Accessed 14 October 2019
Chaiamnuay P, Darmawan J, Muirden K, Assawatanabodee P (1998) Epidemiology of rheumatic disease in rural Thailand: a WHO-ILAR COPCORD study. Community Oriented Programme for the Control of Rheumatic Disease. J Rheumatol 25:1382–1387
Chung WS, Lin CL, Peng CL, Chen YF, Lu CC, Sung FC, Kao CH (2013) Rheumatoid arthritis and risk of acute myocardial infarction–a nationwide retrospective cohort study. Int J Cardiol 168:4750–4754. https://doi.org/10.1016/j.ijcard.2013.07.233
Kuo CF, Luo SF, See LC, Chou IJ, Chang HC, Yu KH (2013) Rheumatoid arthritis prevalence, incidence, and mortality rates: a nationwide population study in Taiwan. Rheumatol Int 33:355–360. https://doi.org/10.1007/s00296-012-2411-7
Sung YK, Cho SK, Choi CB, Bae SC (2013) Prevalence and incidence of rheumatoid arthritis in South Korea. Rheumatol Int 33:1525–1532. https://doi.org/10.1007/s00296-012-2590-2
Yu KH, See LC, Kuo CF, Chou IJ, Chou MJ (2013) Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan. Arthritis Care Res 65:244–250. https://doi.org/10.1002/acr.21820
Hunter TM, Boytsov NN, Zhang X, Schroeder K, Michaud K, Araujo AB (2017) Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014. Rheumatol Int 37:1551–1557. https://doi.org/10.1007/s00296-017-3726-1
Aho K, Heliovaara M, Sievers K, Maatela J, Isomaki H (1989) Clinical arthritis associated with positive radiological and serological findings in Finnish adults. Rheumatol Int 9:7–11
Reyes Llerena GA, Guibert Toledano M, Hernandez Martinez AA, Gonzalez Otero ZA, Alcocer Varela J, Cardiel MH (2000) Prevalence of musculoskeletal complaints and disability in Cuba. A community-based study using the COPCORD core questionnaire. Clin Exp Rheumatol 18:739–742
Moolenburgh JD, Valkenburg HA, Fourie PB (1986) A population study on rheumatoid arthritis in Lesotho, southern Africa. Ann Rheum Dis 45:691–695
Senna ER, De Barros ALP, Silva EO, Costa IF, Pereira LVB, Ciconelli RM, Ferraz MB (2004) Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol 31:594–597
Spindler A, Bellomio V, Berman A, Lucero E, Baigorria M, Paz S, Garrone N, Torres AI, Romano O, Carraccio A, Leal O, Bazzano A, Vazquez D, Pera O, Arquez G, Valdez M, Lazaro H, Rengel S, Acosta E, Santana M (2002) Prevalence of rheumatoid arthritis in Tucuman, Argentina. J Rheumatol 29:1166–1170
Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA (1957) Proposed diagnostic criteria for rheumatoid arthritis: report of a study conducted by a committee of the American Rheumatism Association. Ann Rheum Dis 16:118
Darmawan J, Muirden KD, Valkenburg HA, Wigley RD (1993) The epidemiology of rheumatoid arthritis in Indonesia. Br J Rheumatol 32:537–540
Kellgren JH (1962) Diagnostic criteria for population studies. Bull Rheum Dis 13:291
Shichikawa K, Inoue K, Hirota S, Maeda A, Ota H, Kimura M, Ushiyama T, Tsujimoto M (1999) Changes in the incidence and prevalence of rheumatoid arthritis in Kamitonda, Wakayama, Japan, 1965–1996. Ann Rheum Dis 58:751–756
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324. https://doi.org/10.1002/art.1780310302
Akar S, Birlik M, Gurler O, Sari I, Onen F, Manisali M, Tirpan K, Demir T, Meral M, Akkoc N (2004) The prevalence of rheumatoid arthritis in an urban population of Izmir-Turkey. Clin Exp Rheumatol 22:416–420
Cakir N, Pamuk ON, Dervis E, Imeryuz N, Uslu H, Benian O, Elelci E, Erdem G, Sarvan FO, Senocak M (2012) The prevalences of some rheumatic diseases in western Turkey: Havsa study. Rheumatol Int 32:895–908. https://doi.org/10.1007/s00296-010-1699-4
Cimmino MA, Parisi M, Moggiana G, Mela GS, Accardo S (1998) Prevalence of rheumatoid arthritis in Italy: the Chiavari Study. Ann Rheum Dis 57:315–318
Della Rossa A, Neri R, Talarico R, Doveri M, Consensi A, Salvadori S, Lorenzoni V, Turchetti G, Bellelli S, Cazzato M, Bazzichi L, Monicelli P, Moscardini S, Bombardieri S (2010) Diagnosis and referral of rheumatoid arthritis by primary care physician: results of a pilot study on the city of Pisa, Italy. Clin Rheumatol 29:71–81. https://doi.org/10.1007/s10067-009-1285-x
Simonsson M, Bergman S, Jacobsson LT, Petersson IF, Svensson B (1999) The prevalence of rheumatoid arthritis in Sweden. Scand J Rheumatol 28:340–343
Carmona L, Villaverde V, Hernandez-Garcia C, Ballina J, Gabriel R, Laffon A (2002) The prevalence of rheumatoid arthritis in the general population of Spain. Rheumatology 41:88–95
Pedersen JK, Svendsen AJ, Hørslev-Petersen K (2011) Prevalence of rheumatoid arthritis in the southern part of denmark. Open Rheumatol J 5:91–97. https://doi.org/10.2174/1874312901105010091
Widdifield J, Paterson JM, Bernatsky S, Tu K, Thorne JC, Ahluwalia V, Ivers N, Butt D, Jaakkimainen RL, Tomlinson G, Bombardier C (2013) The rising burden of rheumatoid arthritis surpasses rheumatology supply in Ontario. Can J Public Health 104:e450-455
Jean S, Hudson M, Gamache P, Bessette L, Fortin PR, Boire G, Bernatsky S (2017) Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study. Clin Rheumatol 36:2667–2671. https://doi.org/10.1007/s10067-017-3796-1
Rossini M, Rossi E, Bernardi D, Viapiana O, Gatti D, Idolazzi L, Caimmi C, Derosa M, Adami S (2014) Prevalence and incidence of rheumatoid arthritis in Italy. Rheumatol Int 34:659–664. https://doi.org/10.1007/s00296-014-2974-6
Neovius M, Simard JF, Askling J (2011) Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden. Ann Rheum Dis 70:624–629. https://doi.org/10.1136/ard.2010.133371
Safiri S, Kolahi AA, Hoy D, Smith E, Bettampadi D, Mansournia MA, Almasi-Hashiani A, Ashrafi-Asgarabad A, Moradi-Lakeh M, Qorbani M, Collins G, Woolf AD, March L, Cross M (2019) Global, regional and national burden of rheumatoid arthritis 1990–2017: a systematic analysis of the Global Burden of Disease study 2017. Ann Rheum Dis 78:1463–1471. https://doi.org/10.1136/annrheumdis-2019-215920
Gonzalez-Chica DA, Vanlint S, Hoon E, Stocks N (2018) Epidemiology of arthritis, chronic back pain, gout, osteoporosis, spondyloarthropathies and rheumatoid arthritis among 1.5 million patients in Australian general practice: NPS MedicineWise MedicineInsight dataset. BMC Musculoskelet Disord 19:20. https://doi.org/10.1186/s12891-018-1941-x
Al Mutairi KB, Nossent JC, Inderjeeth CA (2020) Validity of self-reported diagnosis of rheumatoid arthritis. J Rheumatol. https://doi.org/10.3899/jrheum.191401
Minichiello E, Semerano L, Boissier M-C (2016) Time trends in the incidence, prevalence, and severity of rheumatoid arthritis: a systematic literature review. Joint Bone Spine 83:625–630. https://doi.org/10.1016/j.jbspin.2016.07.007
Nair BV, Schuler R, Stewart S, Taylor-Gjevre RM (2016) Self-Reported Barriers to Healthcare Access for Rheumatoid Arthritis Patients in Rural and Northern Saskatchewan: A Mixed Methods Study. Musculoskelet Care 14:243–251. https://doi.org/10.1002/msc.1146
Symmons DPM (2002) Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome. Best Pract Res Clin Rheumatol 16:707–722. https://doi.org/10.1053/berh.2002.0257
Del Rincón I, Williams K, Stern MP, Freeman GL, Escalante A (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44:2737–2745
Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52:722–732
Gabriel SE, Michaud K (2009) Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 11:229–244. https://doi.org/10.1186/ar2669
Guevara-Pacheco S, Feican-Alvarado A, Sanin LH, Vintimilla-Ugalde J, Vintimilla-Moscoso F, Delgado-Pauta J, Lliguisaca-Segarra A, Dutan-Erraez H, Guevara-Mosquera D, Ochoa-Robles V, Cardiel MH, Pelaez-Ballestas I (2016) Prevalence of musculoskeletal disorders and rheumatic diseases in Cuenca, Ecuador: a WHO-ILAR COPCORD study. Rheumatol Int 36:1195–1204. https://doi.org/10.1007/s00296-016-3446-y
Gomez D, Saavedra-Martinez G, Villarreal L, Santos-Moreno P, Bello-Gualtero J, Giraldo V, Martinez P, Sanchez A, Sanchez M, Uribe E, Boon M (2015) misdiagnosis of rheumatoid arthritis—the photography. Ann Rheum Dis 74:689
Hammer GP, du Prel J-B, Blettner M (2009) Avoiding bias in observational studies: part 8 in a series of articles on evaluation of scientific publications. Dtsch Arztebl Int 106:664–668. https://doi.org/10.3238/arztebl.2009.0664
Hackshaw A (2008) Small studies: strengths and limitations. Eur Respir J 32:1141–1143. https://doi.org/10.1183/09031936.00136408
Galea S, Tracy M (2007) Participation rates in epidemiologic studies. Ann Epidemiol 17:643–653. https://doi.org/10.1016/j.annepidem.2007.03.013
Ward MM (2013) Estimating disease prevalence and incidence using administrative data: some assembly required. J Rheumatol 40:1241–1243. https://doi.org/10.3899/jrheum.130675
Moens HJB, van de Laar MA, van der Korst JK (1992) Comparison of the sensitivity and specificity of the 1958 and 1987 criteria for rheumatoid arthritis. J Rheumatol 19:198–203
Mjaavatten MD, Bykerk VP (2013) Early rheumatoid arthritis: the performance of the 2010 ACR/EULAR criteria for diagnosing RA. Best Pract Res Clin Rheumatol 27:451–466. https://doi.org/10.1016/j.berh.2013.09.001
Combe B, Gottenberg J-E, Ravaud P, Mariette X (2010) Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries. Rheumatology 50:222–229. https://doi.org/10.1093/rheumatology/keq368
Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409–1417. https://doi.org/10.1007/s00296-011-1999-3
Acknowledgements
KA was supported by an Australian Government Research Training Program PhD Scholarship at the University of Western Australia (UWA). We acknowledge senior librarian Samantha Blake (SB) for her help within the scope of UWA library support services for systematic reviewers.
Funding
This meta-analysis was not funded, and no funding agencies had input into the design or conduct of this review.
Author information
Authors and Affiliations
Contributions
Conceptualization: KA, JN, DP, and CI. Data curation: KA, JN, and CI. Formal analysis: KA, JN, and CI. Software: KA. Writing—original draft: KA. Writing—review and editing: KA, JN, DP, HK, and CI. Supervision: JN, DP, HK, and CI.
Corresponding author
Ethics declarations
Conflict of interest
The authors have declared no conflicts of interest.
Ethical approval
This meta-analysis relies solely on data obtained from published research literature and, therefore, obtaining institutional ethical approval was not required.
Consent of publication
All authors agreed to publish in Rheumatology International Journal.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Almutairi, K., Nossent, J., Preen, D. et al. The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int 41, 863–877 (2021). https://doi.org/10.1007/s00296-020-04731-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-020-04731-0